BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 235,600 shares, a growth of 81.0% from the January 15th total of 130,200 shares. Based on an average daily volume of 72,300 shares, the days-to-cover ratio is presently 3.3 days. Currently, 4.6% of the shares of the stock are sold short.

BioRestorative Therapies Stock Performance

Shares of NASDAQ:BRTX traded down $0.17 on Friday, reaching $2.29. The company’s stock had a trading volume of 86,795 shares, compared to its average volume of 75,317. The company has a 50-day simple moving average of $1.86 and a 200 day simple moving average of $1.68. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The company has a market cap of $15.85 million, a P/E ratio of -1.50 and a beta of 62.62.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The company had revenue of $0.23 million during the quarter, compared to analyst estimates of $0.30 million. On average, equities research analysts forecast that BioRestorative Therapies will post -1.43 EPS for the current fiscal year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.